No abstract available
MeSH terms
-
Angiogenesis Inhibitors / adverse effects
-
Angiogenesis Inhibitors / therapeutic use*
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antibodies, Monoclonal, Humanized
-
Cardiovascular Diseases / mortality*
-
Humans
-
Injections, Intraocular
-
Ranibizumab
-
Risk Factors
-
Vascular Endothelial Growth Factor A / antagonists & inhibitors
-
Wet Macular Degeneration / drug therapy*
-
Wet Macular Degeneration / prevention & control
Substances
-
Angiogenesis Inhibitors
-
Antibodies, Monoclonal
-
Antibodies, Monoclonal, Humanized
-
Vascular Endothelial Growth Factor A
-
Ranibizumab